Laser Therapy in Superficial Morphea Lesions: Indications, Limitations, and Therapeutic Alternatives

The article reviewed the use of laser therapy for treating superficial morphea lesions, an autoimmune inflammatory skin condition. It highlighted that excimer laser therapy using UVB 308 nm was effective for inflammatory lesions, particularly on erythematous plaques and edematous patches, when topical steroids were ineffective. The study emphasized that treatment was most effective during the inflammatory phase, with high potency steroids and phototherapy showing the best results. It also noted the chronic nature of morphea, affecting both children and adults, and the challenges in treating atrophic lesions and sclerosis, with systemic therapy necessary for severe cases. Phototherapy was recognized for its ability to reduce inflammation and potentially modulate the immune response.